SEC Form 4 · accession 0001225208-18-009759
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kieran Gallahue
Director
Period of report
May 18, 2018
Accepted (ET)
May 22, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2018 | G | 2,034 | $0.00 | D | 0 | D | |
| Common StockF1 | May 18, 2018 | A | 1,655 | $0.00 | A | 1,655 | D | |
| Common StockF2 | May 18, 2018 | A | 479 | $0.00 | A | 2,134 | D | |
| Common Stock | May 12, 2018 | G | 2,034 | $0.00 | A | 13,600 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units were granted on May 18, 2018 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program. They are scheduled to become vested 100% after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the reporting person ceases to serve on Issuer's Board.
- F2This restricted stock was granted on May 18, 2018 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and is scheduled to become vested 100% after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Exhibit 24, Power of Attorney, attached.